Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|February 1, 1979
Fluorescamine use in high-performance liquid chromatographic determination of aminocaproic acid in serumN A FaridJournal of Chromatography. B, Biomedical Sciences and Applications|March 28, 1997
High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY191704, a human type 1 5 alpha-reductase inhibitor, in plasmaN A Farid, N L ColemanTalanta|July 1, 1973
Thin-layer chromatographic method for separation and determination of papaverine and its oxidation productsG M Habashy, N A FaridRadiology|September 1, 1983
Tc-99m labeled leukocytes: preparation and use in identification of abscess and tissue rejectionN A Farid, S M White, L L Heck, et al.Life Sciences|January 1, 1988
Pressor responses to tyramine and norepinephrine after subchronic administration of fluoxetine to manD J Bowsher, H Rowe, N A Farid, et al.Journal of Clinical Pharmacology|May 1, 1985
Single-dose and steady-state pharmacokinetics of tomoxetine in normal subjectsN A Farid, R F Bergstrom, E A Ziege, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|August 19, 2007
Disposition and metabolic fate of prasugrel in mice, rats, and dogsR L Smith, T A Gillespie, T J Rash, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|December 19, 2002
Disposition of LY333531, a selective protein kinase C beta inhibitor, in the Fischer 344 rat and beagle dogJ L Burkey, K M Campanale, D D O'Bannon, et al.International Journal of Pharmaceutics|April 18, 2000
Salt form selection and characterization of LY333531 mesylate monohydrateG L Engel, N A Farid, M M Faul, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 23, 2009
Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrelY Nishiya, K Hagihara, A Kurihara, et al.Pageof 3